OxyContin

As national distributors and pharmacies restricted the flow of painkillers in response to the opioid crisis, Florida’s most popular grocer did the opposite, according to a Tampa Bay Times data analysis.

Under the agreement, McKinsey must establish a fund to reimburse insurers, private benefit plans and others for some or all of their prescription opioid costs.

The justices struggled to decide whether to give a thumbs up or thumbs down to the multibillion dollar Purdue Pharma bankruptcy deal -- a deal meant to compensate victims of OxyContin.

In exchange for giving up ownership of drug manufacturer Purdue Pharma and for contributing up to $6 billion to fight the crisis, members of the wealthy Sackler family would be exempt from any civil lawsuits

A federal judge has overturned a bankruptcy settlement worth more than $4 billion that granted immunity from opioid lawsuits to members of the family who owns the company that makes OxyContin.

With a federal judge poised to approve Purdue Pharma's controversial Chapter 11 plan, the company is working behind the scenes to preempt a legal challenge by the Justice Department.

Massachusetts and New York are among the states agreeing to end the fight to halt a controversial Purdue Pharma bankruptcy plan. The deal shelters members of the Sackler family from opioid lawsuits.

If the bankruptcy plan is approved, Florida could get up to $280 million to $400 million over a 10-year period.

Under a bankruptcy plan filed late Monday, the OxyContin maker would pay $500 million up front, promising billions in future payments. Twenty-four states rejected the proposal.

Critics say the settlement doesn't hold company executives or members of the Sackler family accountable for their aggressive marketing of OxyContin, which helped fuel the nation's opioid epidemic.